{"id":"W2810063204","doi":"10.1016/j.jval.2018.04.044","title":"Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1: A Canadian Cost-Utility Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Rilpivirine; Dolutegravir; Human immunodeficiency virus (HIV); Medicine; Virology; Antiretroviral therapy; Viral load","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004106176,0.001387837,0.001893533,0.003003186,0.001000036,0.00242188,0.001766442,0.0008158673,0.004405606],"category_scores_gemma":[0.01205795,0.0006560041,0.005561037,0.006637634,0.0006840869,0.0008313677,0.0008767708,0.002182496,0.0001585151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07685245,"about_ca_system_score_gemma":0.05586807,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9695417,"about_ca_topic_score_gemma":0.9738169,"domain_scores_codex":[0.9967545,0.001276604,0.000156151,0.0001630774,0.001134023,0.0005156543],"domain_scores_gemma":[0.9960879,0.002023924,0.0002861319,0.0001101998,0.001087413,0.0004044061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.06541803,0.002046558,0.1915438,0.009711298,0.0252019,0.001565441,0.0009970092,0.2759889,0.002128361,0.02646285,0.05487877,0.344057],"study_design_scores_gemma":[0.01569393,0.00474934,0.5268587,0.003169367,0.04716796,0.001451875,0.00289132,0.3255436,0.00111965,0.007866065,0.06264201,0.0008461887],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8276883,0.07548939,0.004591905,0.007498042,0.0002731153,0.002603545,0.04047458,0.0001303011,0.04125079],"genre_scores_gemma":[0.9700252,0.01530219,0.003289836,0.0006603027,0.00005002498,0.0002150572,0.006695822,0.00004803946,0.003713498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07685245,"threshold_uncertainty_score":0.5576062,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02129407065361259,"score_gpt":0.2763232802801294,"score_spread":0.2550292096265168,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}